Assignee
ZAFGEN INC
US·35 granted patents·32 pending applications·173 citations·filing 2012–2019
Top patents by PatentIndex Score
67 records- 0198US8367721B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2012·Granted Feb 5, 2013·57 cites·2 claims
- 0296US9682965B2Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Granted Jun 20, 2017·8 cites·9 claims
- 0394US9000035B2Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2013·Granted Apr 7, 2015·18 cites·12 claims
- 0494US8980946B2Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2013·Granted Mar 17, 2015·19 cites·6 claims
- 0594US8349891B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted Jan 8, 2013·28 cites·21 claims
- 0689US8735447B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted May 27, 2014·5 cites·17 claims
- 0787US9573918B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Feb 21, 2017·6 cites·17 claims
- 0886US9649293B2Methods of treating an overweight subjectZAFGEN INC·Filed 2014·Granted May 16, 2017·4 cites·10 claims
- 0985US9597309B2Methods of treating renal disease and other disordersZAFGEN INC·Filed 2014·Granted Mar 21, 2017·2 cites·16 claims
- 1083US9067913B2Fumigillol type compounds and methods of making and using sameZAFGEN INC·Filed 2014·Granted Jun 30, 2015·4 cites·3 claims
- 1181US10023561B2Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Jul 17, 2018·1 cites·6 claims
- 1281US9359369B2Tricyclic sulfonamide compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Jun 7, 2016·5 cites·26 claims
- 1378US9446016B2Methods of treating age related disordersZAFGEN INC·Filed 2014·Granted Sep 20, 2016·2 cites·10 claims
- 1478US9371312B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2014·Granted Jun 21, 2016·1 cites·9 claims
- 1577US9895339B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Feb 20, 2018·1 cites·21 claims
- 1676US9827221B2Crystalline solids of a metAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2016·Granted Nov 28, 2017·1 cites·7 claims
- 1776US9440943B2Tricyclic sulfone compounds and methods of making and using sameZAFGEN INC·Filed 2013·Granted Sep 13, 2016·3 cites·23 claims
- 1875US9839622B2Methods of treating hypothalamic obesityZAFGEN INC·Filed 2013·Granted Dec 12, 2017·2 cites·2 claims
- 1975US9701651B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2015·Granted Jul 11, 2017·1 cites·2 claims
- 2074US9617237B2Partially saturated tricyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Granted Apr 11, 2017·1 cites·2 claims
- 2173US9944613B2Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Apr 17, 2018·1 cites·14 claims
- 2273US2019084968A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 2372US10064839B2Methods of treating liver diseasesZAFGEN INC·Filed 2016·Granted Sep 4, 2018·1 cites·10 claims
- 2472US9656979B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2015·Granted May 23, 2017·1 cites·7 claims
- 2572US2019224156A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2018·Application pending·0 cites
- 2670US9561209B2Methods of treating liver diseasesZAFGEN INC·Filed 2013·Granted Feb 7, 2017·1 cites·13 claims
- 2770US2015209320A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2013·Application pending·0 cites
- 2869US10231946B2Methods of treating ischemic organ damage and other disordersZAFGEN INC·Filed 2017·Granted Mar 19, 2019·0 cites·10 claims
- 2968US2019084969A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 3068US2018064677A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2017·Application pending·0 cites
- 3166US2018016249A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2017·Application pending·0 cites
- 3265US10220015B2Fumigillol compounds and methods of making and using sameZAFGEN INC·Filed 2018·Granted Mar 5, 2019·0 cites·6 claims
- 3364US2015157595A1Methods of treating a subject with benign prostate hyperplasiaZAFGEN INC·Filed 2014·Application pending·0 cites
- 3463US10406134B2Methods of treating an overweight subjectZAFGEN INC·Filed 2017·Granted Sep 10, 2019·0 cites·7 claims
- 3563US2018221328A1Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl FumagillolZAFGEN INC·Filed 2017·Application pending·0 cites
- 3663US2019388380A1Fumagillol type compounds and methods of making and using sameZAFGEN INC·Filed 2019·Application pending·0 cites
- 3762US2018230137A1Fumagillol heterocyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Application pending·0 cites
- 3862US2015216835A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2014·Application pending·0 cites
- 3962US2017209596A1Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the SameZAFGEN INC·Filed 2016·Application pending·0 cites
- 4060US10259796B2Oxaspiro[2.5]octane derivatives and analogsZAFGEN INC·Filed 2017·Granted Apr 16, 2019·0 cites·9 claims
- 4160US9849106B2Methods of treating impaired wound healingZAFGEN INC·Filed 2017·Granted Dec 26, 2017·0 cites·15 claims
- 4260US2014107171A1Methods of Treating an Overweight or Obese SubjectZAFGEN INC·Filed 2013·Application pending·0 cites
- 4360US2019022051A1Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2018·Application pending·0 cites
- 4459US9925166B2Methods of treating an overweight or obese subjectZAFGEN INC·Filed 2016·Granted Mar 27, 2018·0 cites·3 claims
- 4559US2020003759A1Methods for identifying metap-2 modulatorsZAFGEN INC·Filed 2018·Application pending·0 cites
- 4659US2020030278A1Pharmaceutical compositions of metap-2 inhibitorsZAFGEN INC·Filed 2018·Application pending·0 cites
- 4758US2019092781A1Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 4857US2019175542A1Methods of treating age related disordersZAFGEN INC·Filed 2018·Application pending·0 cites
- 4957US2016243073A1Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl FumagillolZAFGEN INC·Filed 2015·Application pending·0 cites
- 5056US2015209321A1Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillolZAFGEN INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →